Acute bacterial conjunctivitis in Assiout, Upper Egypt. A one-year study.
D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003231:Conjunctivitis / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D004352:Drug Resistance, Microbial; D004534:Egypt; D004926:Escherichia coli / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000382:microbiology; D005260:Female; D006190:Haemophilus / Q000302:isolation & purification; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009016:Moraxella / Q000302:isolation & purification; D009344:Neisseria gonorrhoeae / Q000302:isolation & purification; D012621:Seasons; D012737:Sex Factors; D013210:Staphylococcus / Q000302:isolation & purification; D013290:Streptococcal Infections / Q000382:microbiology; D013291:Streptococcus / Q000302:isolation & purification; D013296:Streptococcus pneumoniae / Q000302:isolation & purification
D000900:Anti-Bacterial Agents